John Barr

1.8k total citations
48 papers, 1.2k citations indexed

About

John Barr is a scholar working on Pharmacology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, John Barr has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Molecular Biology and 7 papers in Pharmaceutical Science. Recurrent topics in John Barr's work include Pharmacogenetics and Drug Metabolism (13 papers), Advanced Drug Delivery Systems (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). John Barr is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Advanced Drug Delivery Systems (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). John Barr collaborates with scholars based in United States, Switzerland and Belgium. John Barr's co-authors include Jorge Heller, Jeffrey P. Jones, Robert Gurny, Steven Y Ng, J. Heller, Klaus Brendel, I.G. Sipes, A. J. Weir, Khadija Schwach‐Abdellaoui and E. Schacht and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

John Barr

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Barr United States 21 383 365 261 229 196 48 1.2k
Guangpu Liu China 21 613 1.6× 543 1.5× 163 0.6× 234 1.0× 90 0.5× 51 1.5k
Meihua Han China 20 482 1.3× 432 1.2× 152 0.6× 288 1.3× 107 0.5× 83 1.3k
Jin‐Seok Choi South Korea 29 401 1.0× 467 1.3× 231 0.9× 262 1.1× 148 0.8× 77 1.9k
Liangke Zhang China 25 502 1.3× 563 1.5× 155 0.6× 601 2.6× 83 0.4× 59 1.8k
Yi Jia China 17 530 1.4× 331 0.9× 125 0.5× 303 1.3× 98 0.5× 36 1.3k
Toshikiro Kimura Japan 22 394 1.0× 257 0.7× 126 0.5× 176 0.8× 98 0.5× 68 1.5k
Isamu Horikoshi Japan 20 410 1.1× 396 1.1× 115 0.4× 240 1.0× 64 0.3× 127 1.2k
Cunxian Duan China 18 527 1.4× 554 1.5× 137 0.5× 193 0.8× 96 0.5× 27 1.4k
Penglong Wang China 16 425 1.1× 299 0.8× 264 1.0× 216 0.9× 122 0.6× 41 1.3k

Countries citing papers authored by John Barr

Since Specialization
Citations

This map shows the geographic impact of John Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Barr more than expected).

Fields of papers citing papers by John Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Barr. The network helps show where John Barr may publish in the future.

Co-authorship network of co-authors of John Barr

This figure shows the co-authorship network connecting the top 25 collaborators of John Barr. A scholar is included among the top collaborators of John Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Barr. John Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barr, John, Zhican Wang, Xiaoshan Min, et al.. (2020). Mechanistic Studies of Cytochrome P450 3A4 Time-Dependent Inhibition Using Two Cysteine-Targeting Electrophiles. Drug Metabolism and Disposition. 48(6). 508–514. 5 indexed citations
2.
Barr, John, Thuy Tran, Brooke M. Rock, Jan L. Wahlstrom, & Upendra P. Dahal. (2020). Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter?. Drug Metabolism and Disposition. 48(8). 613–621. 18 indexed citations
3.
Barr, John, et al.. (2019). Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate. Drug Metabolism and Disposition. 47(4). 419–423. 12 indexed citations
4.
Barr, John, Jeffrey P. Jones, Nicholas H. Oberlies, & Mary F. Paine. (2014). Inhibition of Human Aldehyde Oxidase Activity by Diet-Derived Constituents: Structural Influence, Enzyme-Ligand Interactions, and Clinical Relevance. Drug Metabolism and Disposition. 43(1). 34–41. 19 indexed citations
5.
Barr, John, et al.. (2014). Enzyme Kinetics, Inhibition, and Regioselectivity of Aldehyde Oxidase. Methods in molecular biology. 1113. 167–186. 14 indexed citations
6.
Barr, John, et al.. (2013). Evaluation of Rhesus Monkey and Guinea Pig Hepatic Cytosol Fractions as Models for Human Aldehyde Oxidase. Drug Metabolism and Disposition. 41(10). 1852–1858. 29 indexed citations
7.
Hayes, Robert P., John Barr, K.M. Lewis, et al.. (2013). Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine. Drug and Alcohol Dependence. 133(2). 344–351. 6 indexed citations
8.
Barr, John & Jeffrey P. Jones. (2012). Evidence for Substrate-Dependent Inhibition Profiles for Human Liver Aldehyde Oxidase. Drug Metabolism and Disposition. 41(1). 24–29. 35 indexed citations
9.
Heller, Jorge & John Barr. (2004). Poly(ortho esters)From Concept to Reality. Biomacromolecules. 5(5). 1625–1632. 107 indexed citations
10.
Toncheva, Veska, et al.. (2003). Use of Block Copolymers of Poly(Ortho Esters) and Poly (Ethylene Glycol) Micellar Carriers as Potential Tumour Targeting Systems. Journal of drug targeting. 11(6). 345–353. 55 indexed citations
11.
Schwach‐Abdellaoui, Khadija, Andrea Mombelli, P Baehni, et al.. (2002). Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans. PubMed. 4(4). 14–20. 31 indexed citations
12.
Barr, John, et al.. (2002). Post surgical pain management with poly(ortho esters). Advanced Drug Delivery Reviews. 54(7). 1041–1048. 9 indexed citations
13.
Heller, Jorge, et al.. (2002). Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery. Journal of Controlled Release. 78(1-3). 133–141. 27 indexed citations
14.
Heller, Jorge, et al.. (2002). Poly(ortho esters): synthesis, characterization, properties and uses. Advanced Drug Delivery Reviews. 54(7). 1015–1039. 247 indexed citations
15.
Schwach‐Abdellaoui, Khadija, Robert Gurny, J. Heller, & John Barr. (2002). Control of Molecular Weight for Auto-Catalyzed Poly(ortho ester) Obtained by Polycondensation Reaction. International Journal of Polymer Analysis and Characterization. 7(1-2). 145–161. 15 indexed citations
16.
Schwach‐Abdellaoui, Khadija, et al.. (2001). Release of BSA from poly(ortho ester) extruded thin strands. Journal of Controlled Release. 71(1). 31–37. 25 indexed citations
17.
Schwach‐Abdellaoui, Khadija, et al.. (2001). Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials. 22(12). 1659–1666. 35 indexed citations
18.
López, Esther, et al.. (2000). Development of a poly(ortho ester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery. Journal of Controlled Release. 65(3). 367–374. 37 indexed citations
19.
Barr, John. (1995). Key Considerations in RFIC Production Test. 36–45. 3 indexed citations
20.
Gunawardhana, Lhanoo, John Barr, A. J. Weir, Klaus Brendel, & I.G. Sipes. (1991). The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.. Drug Metabolism and Disposition. 19(3). 648–654. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026